Free Trial

Atossa Genetics (ATOS) Stock Price, News & Analysis

Atossa Genetics logo
$0.89 -0.02 (-2.54%)
Closing price 04:00 PM Eastern
Extended Trading
$0.90 +0.01 (+1.50%)
As of 04:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Atossa Genetics Stock (NASDAQ:ATOS)

Key Stats

Today's Range
$0.86
$0.92
50-Day Range
$0.76
$1.03
52-Week Range
$0.55
$1.66
Volume
605,972 shs
Average Volume
751,931 shs
Market Capitalization
$115.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.17
Consensus Rating
Buy

Company Overview

Atossa Genetics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
63rd Percentile Overall Score

ATOS MarketRank™: 

Atossa Genetics scored higher than 63% of companies evaluated by MarketBeat, and ranked 390th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Atossa Genetics has received a consensus rating of Buy. The company's average rating score is 3.33, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Atossa Genetics has only been the subject of 2 research reports in the past 90 days.

  • Read more about Atossa Genetics' stock forecast and price target.
  • Earnings Growth

    Earnings for Atossa Genetics are expected to decrease in the coming year, from ($0.22) to ($0.28) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Atossa Genetics is -4.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Atossa Genetics is -4.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Atossa Genetics has a P/B Ratio of 1.56. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Atossa Genetics' valuation and earnings.
  • Percentage of Shares Shorted

    3.91% of the float of Atossa Genetics has been sold short.
  • Short Interest Ratio / Days to Cover

    Atossa Genetics has a short interest ratio ("days to cover") of 4.9.
  • Change versus previous month

    Short interest in Atossa Genetics has recently decreased by 37.06%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Atossa Genetics does not currently pay a dividend.

  • Dividend Growth

    Atossa Genetics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.91% of the float of Atossa Genetics has been sold short.
  • Short Interest Ratio / Days to Cover

    Atossa Genetics has a short interest ratio ("days to cover") of 4.9.
  • Change versus previous month

    Short interest in Atossa Genetics has recently decreased by 37.06%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Atossa Genetics has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.97 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Atossa Genetics this week, compared to 2 articles on an average week.
  • Search Interest

    20 people have searched for ATOS on MarketBeat in the last 30 days. This is an increase of 150% compared to the previous 30 days.
  • MarketBeat Follows

    4 people have added Atossa Genetics to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Atossa Genetics insiders have bought more of their company's stock than they have sold. Specifically, they have bought $9,890.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 8.70% of the stock of Atossa Genetics is held by insiders.

  • Percentage Held by Institutions

    Only 12.74% of the stock of Atossa Genetics is held by institutions.

  • Read more about Atossa Genetics' insider trading history.
Receive ATOS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Atossa Genetics and its competitors with MarketBeat's FREE daily newsletter.

ATOS Stock News Headlines

$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.
See More Headlines

ATOS Stock Analysis - Frequently Asked Questions

Atossa Genetics' stock was trading at $0.9441 at the beginning of 2025. Since then, ATOS shares have decreased by 5.6% and is now trading at $0.8910.

Atossa Genetics Inc. (NASDAQ:ATOS) announced its quarterly earnings results on Tuesday, May, 13th. The company reported ($0.05) earnings per share for the quarter, beating the consensus estimate of ($0.06) by $0.01.

Atossa Genetics's stock reverse split before market open on Friday, April 20th 2018.The 1-12 reverse split was announced on Friday, April 20th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, April 19th 2018. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split.

Shares of ATOS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Atossa Genetics investors own include Zomedica (ZOM), AU Optronics (AUOTY), Voyager Therapeutics (VYGR), DiamondRock Hospitality (DRH), Waste Connections (WCN), American Water Works (AWK) and The RMR Group (RMR).

Company Calendar

Last Earnings
5/13/2025
Today
7/16/2025
Next Earnings (Estimated)
8/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ATOS
CIK
1488039
Employees
8
Year Founded
2009

Price Target and Rating

High Price Target
$7.50
Low Price Target
$4.00
Potential Upside/Downside
+594.4%
Consensus Rating
Buy
Rating Score (0-4)
3.33
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.21)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$25.50 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-33.90%
Return on Assets
-31.53%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
12.67
Quick Ratio
12.67

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.57 per share
Price / Book
1.56

Miscellaneous

Outstanding Shares
129,170,000
Free Float
117,932,000
Market Cap
$114.70 million
Optionable
Optionable
Beta
0.90

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:ATOS) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners